Matches in Nanopublications for { ?s ?p "[In this study, we genetically engineered old human MSCs (O-hMSCs) with tissue inhibitor of matrix metalloproteinase-3 (TIMP3) and vascular endothelial growth factor (VEGF) and evaluated the effects on the efficacy of cell-based gene therapy in a rat myocardial infarction (MI) model.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 2 of
2
with 100 items per page.
- NP497829.RAfsqolENEY0NcC-5bI_o0LM1PLzeF0ouMhb78bpgbuCk130_assertion description "[In this study, we genetically engineered old human MSCs (O-hMSCs) with tissue inhibitor of matrix metalloproteinase-3 (TIMP3) and vascular endothelial growth factor (VEGF) and evaluated the effects on the efficacy of cell-based gene therapy in a rat myocardial infarction (MI) model.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP497829.RAfsqolENEY0NcC-5bI_o0LM1PLzeF0ouMhb78bpgbuCk130_provenance.
- NP662412.RA2MHu53uQGRbaUlt1-GEJPdlyyS-SqNA3mO_te6dx7u0130_assertion description "[In this study, we genetically engineered old human MSCs (O-hMSCs) with tissue inhibitor of matrix metalloproteinase-3 (TIMP3) and vascular endothelial growth factor (VEGF) and evaluated the effects on the efficacy of cell-based gene therapy in a rat myocardial infarction (MI) model.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP662412.RA2MHu53uQGRbaUlt1-GEJPdlyyS-SqNA3mO_te6dx7u0130_provenance.